2017
DOI: 10.22159/ajpcr.2017.v10i4.14334
|View full text |Cite
|
Sign up to set email alerts
|

Sertraline induced hyponatremia

Abstract: A 53-year-old female patient with a history of carcinoma of the breast in remission and dilated cardiomyopathy on treatment was newly diagnosed with depression. She was started on sertraline 50 mg once a day. 2 days later she developed severe hyponatremia (serum sodium 114 mEq/l). Her condition further deteriorated and on the 6 th day her medication was stopped and replaced with mirtazapine. Osmolality studies she was diagnosed with syndrome of inappropriate antidiuretic hormone secretion. She was treated with… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

1
0
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 9 publications
1
0
0
Order By: Relevance
“…13 C NMR (400 MHz, CDCl 3 ): δ = 190.67, 159.76, 145.17, 143.47, 136.04, 130.53, 129.36, 128.67, 126.78, 119.14, 116.28, 21.71. The NMR data were in accordance to the literature values [16]. (2E)-3-(4-hydroxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1one (1 c)(yellow solid, 643 mg, 81% i.y.).…”
supporting
confidence: 88%
“…13 C NMR (400 MHz, CDCl 3 ): δ = 190.67, 159.76, 145.17, 143.47, 136.04, 130.53, 129.36, 128.67, 126.78, 119.14, 116.28, 21.71. The NMR data were in accordance to the literature values [16]. (2E)-3-(4-hydroxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1one (1 c)(yellow solid, 643 mg, 81% i.y.).…”
supporting
confidence: 88%